Professional Marketing briefs: May 2012

Professional Marketing briefs: May 2012
Professional Marketing briefs: May 2012

Daiichi ­Sankyo has a new global slogan: “Passion for Innovation. Compassion for Patients.” It will be the first uniform slogan for the company since the 2006 merger of Daiichi Pharmaceutical and Sankyo. Marah Binder, DSI senior manager for corporate public relations, told MM&M the company had been sifting through iterations for more than a year.

Strategy firm Delta Point and videoconferencing group Doctor Insights announced the formalization of their partnership. Delta Point CEO Jerry Acuff told MM&M that the groups have worked together for about a year. He said Doctor Insights is mainly a focus-group recruiting service that helps find candidates as well as ships equipment to doctors so they can log in and participate from their offices or homes.

Corcept Therapeutics launched its Cushing's syndrome drug on April 11—three days after Cushing's Awareness Day and three weeks earlier than expected. Korlym (mifepristone) will wholesale at $0.62 per milligram, or $186 per 300-mg tablet, VP of commercial operations Steven Lo told MM&M. The FDA approved the daily treatment in February. It's the first FDA-sanctioned drug for the rare disease.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


Investment in healthcare IT stands at an all-time high. The government has spent billions to promote EHR adoption. Yet the physician wish list is a mile long, while hospitals and patients are not where they need to be. To peel back the layers of what we've all been waiting for in the Great Data Capture of the 21st Century, and to review the changes enabling the healthcare data ecosystem to coexist, MM&M presents this e-Book. Click here.


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.